Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Nuclear Medicine & Medical Imaging Radiology. Found 15 abstracts

Bagshaw H, Ruth K, Horwitz EM, Chen DY, Buyyounouski MK. Does family history of prostate cancer affect outcomes following radiotherapy?. Radiotherapy and Oncology. 2014 Feb;110(2):229-34.   PMCID: 3991234
Kang SW, Lang JY, Wang P, Li J, Lin MH, Chen XM, Guo M, Chen F, Chen LL, Ma CM. Optimization strategies for pulsed low-dose-rate IMRT of recurrent lung and head and neck cancers. Journal of Applied Clinical Medical Physics. 2014 Jan;15(3):102-13.
Chen Z, Ma CM, Paskalev K, Li J, Yang J, Richardson T, Palacio L, Xu X, Chen L. Investigation of MR image distortion for radiotherapy treatment planning of prostate cancer. PHYSICS IN MEDICINE AND BIOLOGY. 2006 Mar;51(6):1393-403.
Chism DB, Freedman GM, Li TY, Anderson PR. Re-excision of margins before breast radiation - Diagnostic or therapeutic?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Aug;65(5):1416-21.
du Plessis FC, Leal A, Stathakis S, Xiong W, Ma CM. Characterization of megavoltage electron beams delivered through a photon multi-leaf collimator (pMLC). PHYSICS IN MEDICINE AND BIOLOGY. 2006 Apr;51(8):2113-29.
Khor LY, DeSilvio M, Li RL, McDonnell TJ, Hammond ME, Sause WT, Pilepich MV, Okunieff P, Sandler HM, Pollack A. Bcl-2 and bax expression and prostate cancer outcome in men treated with radiotherapy in Radiation Therapy Oncology Group protocol 86-10. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Sep;66(1):25-30.
Konski A, DeSilvio M, Hartsell W, Watkins-Bruner D, Coyne J, Scarantino C, JanJan N. Continuing evidence for poorer treatment outcomes for single male patients: Retreatment data from RTOG 97-14. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Sep;66(1):229-33.
Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP, Zietman AL, Zelefsky MJ, Pisansky TM, Elshaikh M, Horwitz EM. Comparison of biochemical failure definitions for permanent prostate brachytherapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Aug;65(5):1487-93.
Ma CM, Maughan RL, Orton CG. Within the next decade conventional cyclotrons for proton radiotherapy will become obsolete and replaced by far less expensive machines using compact laser systems for the acceleration of the protons. MEDICAL PHYSICS. 2006 Mar;33(3):571-3.
Movsas B, Scott C, Watkins-Bruner D. Pretreatment factors significantly influence quality of life in cancer patients: A radiation therapy oncology group (RTOG) analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(3):830-5.
Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CM, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Feb;64(2):518-26.
Price RA, Hannoun-Levi JM, Horvvitz E, Buyyounouski M, Ruth KJ, Ma CM, Pollack A. Impact of pelvic nodal irradiation with intensity-modulated radiotherapy on treatment of prostate cancer. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Oct;66(2):583-92.
Ray ME, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Shipley WU, Zelefsky MJ, Zietman AL, Kuban DA. PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: A multi-institutional analysis. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Mar;64(4):1140-50.
Roach M, Hanks G, Thames H, Schellhammer P, Shipley WU, Sokol GH, Sandler H. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(4):965-74.
Thames HD, Kuban DA, DeSilvio ML, Levy LB, Horwitz EM, Kupelian PA, Martinez AA, Michalski JM, Pisansky TM, Sandler HM, Shipley WU, Zelefsky MJ, Zietman AL. Increasing external beam dose for T1-T2 prostate cancer: Effect on risk groups. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Jul;65(4):975-81.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Nuclear Medicine & Medical Imaging Radiology

Nuclear Medicine & Medical Imaging Radiology Oncology radiotherapy radiation-therapy carcinoma prostate cancer dosimetry survival radical prostatectomy cancer intensity-modulated radiotherapy dose-escalation IMRT radiation therapy breast-cancer conformal radiotherapy Biomedical Engineering brachytherapy irradiation toxicity local recurrence immunohistochemical analysis pretreatment nomogram lung cancer marital-status scores target volume breast cancer Bcl-2 whole pelvic radiotherapy in-vivo chemotherapy H&N reduction disease-free survival positive margins beams therapy conservative surgery questionnaire iii randomized trial alpha 70 gy denmark conserving therapy radiology bone metastases p53 late rectal toxicity phase-iii biochemical recurrence seed implantation intensity modulation biochemical failure surgical margin quality of life hypofractionation modulated radiation-therapy external beam radiotherapy Radiotherapy tumors eortc qlq-c30 film implant adjuvant androgen ablation era brain-tumors antigen nadir stage t1-t2 HYPERSENSITIVITY apoptosis definitions rectum localized carcinoma population external-beam radiotherapy CELLS PSA androgen deprivation ki-67 escalation PSA nadir PSA failure Prostate cancer follow-up fluence phase-iii trial recurrent cancer ct small-bowel monte-carlo prostate cancer patients intraindividual changes pelvic lymphatics socioeconomic-status neoadjuvant hormonal-therapy risk groups american-society failure multi-institutional analysis pretreatment factors beta-ratio optimization stage-i fractionation dose-response oncology consensus definition Family history pulsed low-dose-rate radiotherapy (PLDR) free survival 20-year follow-up clinical disease-free survival RETREATMENT STRATEGY androgen ablation systemic therapy palliation bax EXTERNAL-BEAM RADIATION imrt segment antigen bounce THERAPY high-energy photon trial psa RATE RADIOTHERAPY recommendations prognostic-significance volume
Last updated on Monday, May 04, 2020